George Koulaouzidis

Dr. George Koulaouzidis

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
GKGeorge Koulaouzidis
George Koulaouzidis
TJTomasz Jadczyk
Tomasz Jadczyk
Dimitris IakovidisDimitris Iakovidis
Dimitris Iakovidis
Anastasios KoulaouzidisAnastasios Koulaouzidis
Anastasios Koulaouzidis
MBMarc Bisnaire
Marc Bisnaire
DCDafni Charisopoulou
Dafni Charisopoulou
Artificial intelligence (AI) is an integral part of clinical decision support systems (CDSS), offering methods to approximate human reasoning and computationally infer decisions. Such methods are generally based on medical knowledge, either directly encoded with rules or automatically extracted from medical data using machine learning (ML). ML techniques, such as Artificial Neural Networks (ANNs) and support vector machines (SVMs), are based on mathematical models with parameters that can be optimally tuned using appropriate algorithms. The ever-increasing computational capacity of today’s computer systems enables more complex ML systems with millions of parameters, bringing AI closer to human intelligence. With this objective, the term deep learning (DL) has been introduced to characterize ML based on deep ANN (DNN) architectures with multiple layers of artificial neurons. Despite all of these promises, the impact of AI in current clinical practice is still limited. However, this could change shortly, as the significantly increased papers in AI, machine learning and deep learning in cardiology show. We highlight the significant achievements of recent years in nearly all areas of cardiology and underscore the mounting evidence suggesting how AI will take a central stage in the field.

1 August 2016 in International Journal of Cardiology
Verified
Journal Article
Closed access
GKGeorge Koulaouzidis
George Koulaouzidis
DID.K. Iakovidis
D.K. Iakovidis
ACA.L. Clark
A.L. Clark

7 March 2024 in Angiology
Verified
Journal Article
Closed access
FDFotis Dimitriadis
Fotis Dimitriadis
SAStelina Alkagiet
Stelina Alkagiet
LTLamprini Tsigkriki
Lamprini Tsigkriki
PKPanagiota Kleitsioti
Panagiota Kleitsioti
GSGeorge Sidiropoulos
George Sidiropoulos
GKGeorge Koulaouzidis
George Koulaouzidis
ChatGPT (Generative Pre-trained Transformer) is a large-scale language processing model, with possibilities for professional patient support in a patient-friendly way. The aim of the study was to examine the accuracy and reproducibility of ChatGPT in answering questions about knowledge and management of heart failure (HF). First, we recorded 47 most frequently asked questions by patients about HF. The answers of ChatGPT to these questions were independently assessed by two researchers. ChatGPT was able to render the definition of the disease in a very simple and explanatory way. It listed a number of the most important causes of HF and the most important risk factors for its occurrence. It provided correct answers about the most important diagnostic tests and why they are recommended. In addition, it answered health and dietary questions, such as the daily fluid and the alcohol intake. ChatGPT listed the most important classes of drugs in HF and their mechanism of action. It also answered with arguments to questions about patient’s sex life, whether they could work, drive, or travel by plane. The performance of ChatGPT was described as very good as it was able to adequately answer all questions posed to it.

1 January 2021 in Gastroenterology Review
Verified
Journal Article
Open access
GKGeorge Koulaouzidis
George Koulaouzidis
DCDafni Charisopoulou
Dafni Charisopoulou
MKMichał Kukla
Michał Kukla
WMWojciech Marlicz
Wojciech Marlicz
GRGrażyna Rydzewska
Grażyna Rydzewska
KSKarolina Skonieczna-Żydecka
Karolina Skonieczna-Żydecka
Introduction Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, which is estimated to affect 20–30% of the adult population in Europe. Several studies have shown an association of NAFLD with multiple cardiovascular risk factors such as abdominal obesity,...

1 March 2015 in International Journal of Cardiology
Verified
Journal Article
Closed access
GKGeorge Koulaouzidis
George Koulaouzidis
Saptarshi DasSaptarshi Das
Saptarshi Das
GCGrazia Cappiello
Grazia Cappiello
EMEvangelos Mazomenos
Evangelos Mazomenos
KMKoushik Maharatna
Koushik Maharatna
JMJohn M. Morgan
John M. Morgan

Verified
Journal Article
Open access
PDF file
GKGeorge Koulaouzidis
George Koulaouzidis
DCDafni Charisopoulou
Dafni Charisopoulou
PBPiotr Bomba
Piotr Bomba
JSJaroslaw Stachura
Jaroslaw Stachura
PGPawel M. Gasior
Pawel M. Gasior
TJTomasz Jadczyk
Tomasz Jadczyk
Robots are defined as programmable machines that can perform specified tasks. Medical robots are emerging solutions in the field of cardiology leveraging recent technological innovations of control systems, sensors, actuators, and imaging modalities. Robotic platforms are successfully applied for percutaneous coronary intervention, invasive cardiac electrophysiology procedures as well as surgical operations including minimally invasive aortic and mitral valve repair, coronary artery bypass procedures, and structural heart diseases. Furthermore, machines are used as staff-assisting tools to support nurses with repetitive clinical duties i.e., food delivery. High precision and resolution allow for excellent maneuverability, enabling the performance of medical procedures in challenging anatomies that are difficult or impossible using conventional approaches. Moreover, robot-assisted techniques protect operators from occupational hazards, reducing exposure to ionizing radiation, and limiting risk of orthopedic injuries. Novel automatic systems provide advantages for patients, ensuring device stability with optimized utilization of fluoroscopy. The acceptance of robotic technology among healthcare providers as well as patients paves the way for widespread clinical application in the field of cardiovascular medicine. However, incorporation of robotic systems is associated with some disadvantages including high costs of installation and expensive disposable instrumentations, the need for large operating room space, and the necessity of dedicated training for operators due to the challenging learning curve of robotic-assisted interventional systems.